John Liu

7.6k total citations · 6 hit papers
126 papers, 4.9k citations indexed

About

John Liu is a scholar working on Surgery, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, John Liu has authored 126 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 17 papers in Pathology and Forensic Medicine and 15 papers in Epidemiology. Recurrent topics in John Liu's work include Dermatology and Skin Diseases (12 papers), Spine and Intervertebral Disc Pathology (10 papers) and Autoimmune and Inflammatory Disorders Research (8 papers). John Liu is often cited by papers focused on Dermatology and Skin Diseases (12 papers), Spine and Intervertebral Disc Pathology (10 papers) and Autoimmune and Inflammatory Disorders Research (8 papers). John Liu collaborates with scholars based in United States, Canada and Germany. John Liu's co-authors include R. J. Rioja, Xiaohang Yue, Alvina D. Chu, Henrique D. Teixeira, Eric L. Simpson, Frank L. Acosta, Andrew Blauvelt, James Whitaker, Uday Kamath and A.M. Gokhale and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

John Liu

118 papers receiving 4.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Evolution of Al-Li Base Products for Aerospace and Space Applications

2012 820 citations R. J. Rioja, John Liu Metallurgical and Materials Transactions A profile →
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

2021 350 citations Emma Guttman‐Yassky, Henrique D. Teixeira et al. profile →
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

2021 305 citations Henrique D. Teixeira, Antonio Costanzo et al. profile →
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

2021 182 citations John Liu et al. profile →
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

2023 124 citations Gerd R Burmester, Stanley Cohen et al. RMD Open profile →
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

2022 122 citations Kim Papp, Hwanhee Hong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Liu United States	34	989	985	964	754	680	126	4.9k
Jonathan Black United States	47	625 0.6×	1.4k 1.4×	101 0.1×	328 0.4×	4.7k 6.9×	346	10.0k
Yanan Zheng China	38	171 0.2×	137 0.1×	87 0.1×	85 0.1×	342 0.5×	198	4.7k
Ryohei Yokoyama Japan	35	169 0.2×	572 0.6×	61 0.1×	589 0.8×	200 0.3×	216	3.9k
Chang Liu China	35	461 0.5×	600 0.6×	33 0.0×	80 0.1×	654 1.0×	418	5.4k
Joaquín Martínez‐López Spain	40	128 0.1×	139 0.1×	52 0.1×	426 0.6×	421 0.6×	418	6.1k
Abbas Rezaei Iran	32	464 0.5×	328 0.3×	28 0.0×	98 0.1×	120 0.2×	267	3.8k
Antti Mäkitie Finland	53	18 0.0×	185 0.2×	158 0.2×	279 0.4×	4.1k 6.0×	528	11.9k
Frank Riedel Germany	38	19 0.0×	86 0.1×	257 0.3×	294 0.4×	824 1.2×	263	4.7k
Andrea Bauer Germany	35	45 0.0×	72 0.1×	2.3k 2.4×	447 0.6×	158 0.2×	188	4.0k
Takashi Sonoda Japan	29	54 0.1×	96 0.1×	48 0.0×	135 0.2×	387 0.6×	157	2.6k

Countries citing papers authored by John Liu

Since Specialization

Citations

This map shows the geographic impact of John Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Liu more than expected).

Fields of papers citing papers by John Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Liu. The network helps show where John Liu may publish in the future.

Co-authorship network of co-authors of John Liu

This figure shows the co-authorship network connecting the top 25 collaborators of John Liu. A scholar is included among the top collaborators of John Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Liu. John Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, John, et al.. (2024). Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings. SHILAP Revista de lepidopterología. 19(6). 2168–2182. 2 indexed citations

Kugener, Guillaume, Dhiraj J. Pangal, Hee Won Lee, et al.. (2024). Simulated outcomes for durotomy repair in minimally invasive spine surgery. Scientific Data. 11(1). 62–62. 4 indexed citations

Raine, Tim, Yoh Ishiguro, David T. Rubin, et al.. (2023). Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme. Journal of Crohn s and Colitis. 18(5). 695–707. 4 indexed citations

Burmester, Gerd R, Stanley Cohen, Kevin Winthrop, et al.. (2023). Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD Open. 9(1). e002735–e002735. 124 indexed citations breakdown →

Katoh, Norito, Masanori Ikeda, Yukihiro Ohya, et al.. (2023). Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study. Dermatology and Therapy. 14(1). 213–232. 5 indexed citations

Blauvelt, Andrew, Barry Ladizinski, Vimal H. Prajapati, et al.. (2023). Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up). Journal of the American Academy of Dermatology. 89(3). 478–485. 23 indexed citations

Guttman‐Yassky, Emma, Jacob P. Thyssen, Jonathan I. Silverberg, et al.. (2022). Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies. Journal of Allergy and Clinical Immunology. 151(1). 172–181. 43 indexed citations

Conaghan, Philip G., Eduardo Mysler, Yoshiya Tanaka, et al.. (2021). Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program. Drug Safety. 44(5). 515–530. 33 indexed citations

Silverberg, Jonathan I., Marjolein de Bruin‐Weller, Thomas Bieber, et al.. (2021). Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results. Journal of Allergy and Clinical Immunology. 149(3). 977–987.e14. 76 indexed citations

10.

Liu, John, et al.. (2020). Strengths-based inquiry of resiliency factors among refugees in Metro Vancouver: A comparison of newly-arrived and settled refugees. Social Science & Medicine. 263. 113243–113243. 13 indexed citations

11.

Burke, Jordan E., John Liu, Jade Sales-Lee, et al.. (2019). A Non-Dicer RNase III and Four Other Novel Factors Required for RNAi-Mediated Transposon Suppression in the Human Pathogenic Yeast Cryptococcus neoformans. G3 Genes Genomes Genetics. 9(7). 2235–2244. 14 indexed citations

12.

Wen, Daizong, Till Utesch, Jun Wu, et al.. (2019). Effects of different protocols of high intensity interval training for VO2max improvements in adults: A meta-analysis of randomised controlled trials. Journal of science and medicine in sport. 22(8). 941–947. 186 indexed citations

13.

Liu, John, et al.. (2018). Fluocinolone acetonide (FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME). Investigative Ophthalmology & Visual Science. 59(9). 4816–4816. 1 indexed citations

14.

Palanisamy, Arun P., Gang Cheng, Alton G. Sutter, et al.. (2013). Mitochondrial Uncoupling Protein 2 Induces Cell Cycle Arrest and Necrotic Cell Death. Metabolic Syndrome and Related Disorders. 12(2). 132–142. 16 indexed citations

15.

Rioja, R. J. & John Liu. (2012). The Evolution of Al-Li Base Products for Aerospace and Space Applications. Metallurgical and Materials Transactions A. 43(9). 3325–3337. 820 indexed citations breakdown →

16.

Liu, John, et al.. (2010). Effects of Tai Chi Training on Improving Physical Function in Patients With Coronary Heart Diseases. Journal of Exercise Science & Fitness. 8(2). 78–84. 10 indexed citations

17.

Chen, Shihui, Yong Tai Wang, & John Liu. (2006). Modified stationary Tai Chi for older adults and individuals with physical disabilities. 22(4). 37–43. 1 indexed citations

18.

Liu, John. (2002). The effect of subcutaneous tumour implantation in a murine lung tumour model. European Journal of Cardio-Thoracic Surgery. 21(4). 616–620. 2 indexed citations

19.

Yu, Jianliang, et al.. (1995). Cloning and characterization of the mouse PIG-A gene. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1255(3). 344–350. 1 indexed citations

20.

Straus, David J., George Y. Wong, John Liu, et al.. (1991). Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. The American Journal of Medicine. 90(3). 328–337. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact